Moreover, whereas hepatic FASN ablation ameliorated hepatic steatosis and improved glucose tolerance in NCD-fed ob/ob mice to a greater extent than in Mc4r-KO mice, it also exacerbated both hyperglycemia in the fed state and liver dysfunction. Here, FASN is linked to fatty liver disease.